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Background and Objectives: Serratia marcescens is an emerging nosocomial pathogen, and the carbapene-
mase blaNDM has been reported in several surveys in Romania. We aimed to investigate the molecular epidemiol-
ogy of S. marcescens in two Romanian hospitals over 2010–15, including a neonatal NDM-1 S. marcescens
outbreak.
Methods: Isolates were sequenced using Illumina technology together with carbapenem-non-susceptible
NDM-1-positive and NDM-1-negative Klebsiella pneumoniae and Enterobacter cloacae to provide genomic con-
text. A subset was sequenced with MinION to fully resolve NDM-1 plasmid structures. Resistance genes, plasmid
replicons and ISs were identified in silico for all isolates; an annotated phylogeny was reconstructed for S. mar-
cescens. Fully resolved study NDM-1 plasmid sequences were compared with the most closely related publicly
available NDM-1 plasmid reference.
Results: 44/45 isolates were successfully sequenced (S. marcescens, n"33; K. pneumoniae, n"7; E. cloacae,
n"4); 10 with MinION. The S. marcescens phylogeny demonstrated several discrete clusters of NDM-1-positive
and -negative isolates. All NDM-1-positive isolates across species harboured a pKOX_NDM1-like plasmid; more
detailed comparisons of the plasmid structures demonstrated a number of differences, but highlighted the
largely conserved plasmid backbones across species and hospital sites.
Conclusions: The molecular epidemiology is most consistent with the importation of a pKOX_NDM1-like plasmid
into Romania and its dissemination amongst K. pneumoniae/E. cloacae and subsequently S. marcescens across
hospitals. The data suggested multiple acquisitions of this plasmid by S. marcescens in the two hospitals studied;
transmission events within centres, including a large outbreak on the Targu Mures neonatal unit; and sharing of
the pKOX_NDM1-like plasmid between species within outbreaks.
Introduction
Carbapenemase-producing Enterobacteriaceae (CPE) have
emerged post-1990 and spread worldwide, representing a serious
clinical threat.1 Although carbapenem resistance can arise through
various mechanisms, acquisition of genes (blaKPC, blaNDM-1,
blaOXA-48) encoding Klebsiella pneumoniae carbapenemase (KPC),
New Delhi metallo-b-lactamase (NDM) and OXA-48 carbapene-
mase, respectively, are currently of most concern. These genes are
readily transmitted intra- and inter-species via mobile genetic ele-
ments that have facilitated their worldwide dissemination.2
Compared with Escherichia coli and K. pneumoniae, two of the
most frequently identified CPE species, Serratia marcescens has
been less commonly associated with any of the major transmissi-
ble carbapenemases, although acquisition of blaKPC has been
described recently in China, Greece and the United States.3–5
S. marcescens has also traditionally been regarded as an
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opportunistic pathogen causing disease in specifically vulnerable
populations, such as neonates.6,7 However, Serratia spp. have
become increasingly adapted to hospital environments and have
emerged as important agents of hospital-acquired infections
affecting all age groups.8–10 The inherent resistance of Serratia
spp. to multiple antimicrobial classes may have facilitated this
adaptation, and leaves few therapeutic options open for treating
carbapenem-resistant S.marcescens infections.11–13
blaNDM-1 has been increasingly reported in patients with health-
care exposure on the Indian subcontinent or in the Balkan
region.1,14,15 The occurrence of blaNDM-1 in S. marcescens appears
rare, with only a handful of isolates identified in Germany,16 the
UK17 and Egypt.18 However, a recent faecal screening/surveillance
project for carbapenemase-producing Gram-negative bacteria in
three Romanian hospitals identified 17 NDM-1 S. marcescens in
clinical, environmental and screening isolates,19 all of which were
from the same neonatal unit at a single hospital, consistent with
an outbreak. PCR-based plasmid analyses identified blaNDM-1 in
association with conjugative IncFII plasmids in both S. marcescens
and K. pneumoniae, suggesting inter-species transfer of blaNDM-1,
possibly from K. pneumoniae into a well-established hospital-
adapted S.marcescens clone.
In this study, we used Illumina (short-read) and MinION (long-
read) WGS of NDM-1- and non-NDM-1 S. marcescens and other
Enterobacteriaceae isolates obtained from: (i) the faecal screen-
ing/surveillance study; (ii) a previous outbreak and sporadic
S. marcescens infections in this neonatal unit; and (iii) a second
hospital in an adjacent county, to investigate the evidence
for nosocomial and inter-hospital dissemination of NDM-1
S. marcescens and the transmission of NDM-1 plasmids amongst
Enterobacteriaceae in this context in Romania.
Materials and methods
Hospital settings
Bacterial isolates were collected from two teaching hospitals located in cen-
tral/north Romania: one in Targu Mures (1099 beds, 42 000 patients/year),
and one in Cluj-Napoca (252 beds, 20 000 patients/year). In Targu Mures,
the neonatology unit had 65 beds [10 were for neonatal intensive care
(NICU), 15 for the care of premature neonates].
Overview of S. marcescens outbreaks in
Targu Mures hospital
During April–June 2010, 11 neonates were found to be colonized (faecal/
pharyngeal) with carbapenem-susceptible S. marcescens, 4 of whom
(36%) developed S. marcescens bacteraemia. Environmental screening did
not identify any source; PFGE (data not shown) was consistent with trans-
mission of a clonal strain with the main vector presumed to be colonized
neonates. The main contributing factors to carbapenem-susceptible
S. marcescens dissemination were thought to be overcrowding in the NICU
and selective pressure exerted by ampicillin/sulbactam and gentamicin
prophylaxis given to high-risk neonates (premature and/or complicated
delivery). All patients survived and the outbreak was declared over in
July 2010.
Sporadic infections with carbapenem-susceptible S. marcescens
recurred in 2012, whilst both colonization events and infections with carba-
penem non-susceptible-K. pneumoniae and carbapenem non-susceptible
E. cloacae occurred during 2012–13 in the NICU and paediatric cardiology
ward. Following this, in August 2014, several cases of carbapenem
non-susceptible S. marcescens pharyngeal colonization occurred in the
neonatology unit and an outbreak was declared in October 2014; enhanced
infection control measures were implemented, including faecal screening
of all admissions/transfers to the unit. At this point, the genetic mechanism
mediating carbapenem resistance was shown by PCR to be blaNDM-1. Six
cases of NDM-1 S. marcescens bacteraemia occurred October–December
2014; ongoing NDM-1 S. marcescens faecal/pharyngeal colonization cases
were identified up until May 2015.
In both outbreaks in the Targu Mures NICU (2010, 2014–15), infection
control measures were reinforced, consisting initially of isolating colonized/
infected patients and their contacts, terminal cleaning with quaternary
ammonium compounds, and special attention to NICU disinfection. At the
same time, hospital staff were re-educated with respect to contact precau-
tions and hand hygiene procedures to try and reduce the risk of any staff–
patient transmission.
Isolates
Targu Mures hospital isolates
Isolates from Targu Mures included those obtained from faecal screens
performed during active carbapenemase surveillance in the 2014–15
S. marcescens outbreak, as well as any clinical carbapenem-non-
susceptible S. marcescens isolated from the neonatal unit. Other
carbapenem-non-susceptible S. marcescens, carbapenem-non-susceptible
K. pneumoniae and carbapenem-non-susceptible E. cloacae obtained from
clinical specimens on other hospital units were also included for
comparison.
Carbapenem-non-susceptible S.marcescens cultured from environmental
screening samples (October 2014–April 2015); previous NDM-1
K. pneumoniae and NDM-1 E. cloacae isolated from clinical specimens; and
carbapenem-susceptible S. marcescens obtained from a previous outbreak in
the same neonatal unit (2010) and from sporadic clinical cases (2012) were
also included in the study. Ethics approval for surveillance was obtained from
the Hospital Research Ethics Committee (#138; 23/12/2013).
Cluj-Napoca hospital isolates
Cluj-Napoca is a city neighbouring Targu Mures (80 km away from Targu
Mures) and patients travel between these cities for medical intervention
not provided locally. A subset of stored S. marcescens isolates with a
carbapenemase-producing phenotype (ertapenem- and meropenem-
resistant and CarbaNP test-positive) from urine samples were randomly
selected to identify evidence for inter-hospital transmission.
Microbiological methods
For faecal screening, a modified method from the US CDC involving enrich-
ment and subculture on selective media [trypticase soy broth (TSB)/
MacConkey! carbapenem] was used.20 In brief, a rectal swab or a small
amount of faecal sample was placed in 5 mL of TSB containing a merope-
nem (10 lg) disc and incubated at 35+2

C overnight. 100 lL of inoculated
TSB was subsequently streaked onto MacConkey agar and carbapenem
discs (ertapenem 10 lg and meropenem 10 lg) were placed on different
sectors of the inoculum (all discs and media from Oxoid, Basingstoke, UK);
screening cut-off values for CPE were applied according to the EUCAST
methodology (v5.0, available at: http://www.eucast.org/fileadmin/src/
media/PDFs/EUCAST_files/Breakpoint_tables/v_5.0_Breakpoint_Table_01.
pdf). Presence of carbapenemases was confirmed phenotypically using the
CARBA NP test (BioMe´rieux, Paris, France) at Cluj-Napoca or by PCR (for
blaNDM, blaKPC, blaIMP and blaVIM) at Targu Mures.
21,22 Clinical specimens
were processed according to local protocols. Species identification was per-
formed using the VITEK 2 (BioMe´rieux); susceptibility testing was performed
by microbroth dilution (TREK Diagnostic Systems, West Sussex, UK) for
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isolates from the faecal surveillance study and by disc diffusion for the
others (EUCAST guidelines).
DNA extractions and Illumina/MinION sequencing
DNA extraction of sub-cultured isolates for Illumina sequencing was per-
formed using the Quickgene commercial kit (Fujifilm, Tokyo, Japan), with
an additional mechanical lysis step following chemical lysis (FastPrep, MP
Biomedicals, Santa Ana, USA). Isolates were sequenced using the Illumina
HiSeq 2500 (150 bp paired-end reads; sequencing coverage100%).
Ten isolates were selected for MinION sequencing based on Illumina
data; isolates were cultured from frozen stocks (#80 C) on Columbia Blood
agar in the presence of three ertapenem discs (10 lg; Oxoid, Thermo Fisher
Scientific, USA) overnight at 37 C. DNA was then extracted using the
Qiagen Genomic tip 100/G kit as per the manufacturer’s instructions
(Qiagen, Venlo, the Netherlands), quantified using the Qubit 2.0
Fluorometer (Life Technologies, USA), and fragment lengths assessed using
the TapeStation 2200 (Agilent, UK).
Library preparation was performed using the 2D native barcoding proto-
col, targeting 8 kb fragments, and with an input of 3–4 lg DNA. All steps
were performed following the manufacturer’s protocol with native barcod-
ing to multiplex two samples per sequencing run (EXP-NBD002 and SQK-
LSK208). Libraries were sequenced using the best available flow cells at the
time (R9.4). Libraries were topped up after 12 h, and sequencing performed
for 48 h in total. Data were base-called in real time via Metrichor, using the
best available workflow at the time (v1.125; November–December 2016
and January 2017; ONT, UK). Insufficient sequence data yields were gener-
ated for two samples (multiplexed in a single run; 7209 and 18ES), requiring
repeat sequencing of the same DNA extract by the same methods. The
sequence data from both runs were merged to generate a final set of data
for further processing.
WGS analysis
For Illumina data, read quality- and adapter-related trimming and filtering
were performed using BBDuk (BBTools; available at https://jgi.doe.gov/
data-and-tools/bbtools/), and species identification was confirmed in silico
on the basis of the top species match identified using Kraken.23 The phylog-
eny of S.marcescens isolates was reconstructed using IQTree24 from a con-
sensus fasta of variant sites generated from mapping to the S. marcescens
reference WW4 (NC_020211.1). Read mapping was performed using
Stampy,25 with mapping and filtering of variant calls based on a set of
thresholds related to base and mapping quality and read coverage, as pre-
viously described.26 For phylogenetic reconstruction, a General Time
Reversible model27 was used with a gamma category allowing variable
mutation rates across sites, and a maximum parsimony starting tree. The
maximum-likelihood phylogeny output by IQTree was then corrected for
recombination using ClonalFrameML28 (default parameters), and visualized
in iTOL.29
De novo assemblies of short-read sequenced isolates were generated
with SPAdes (v3.6; default settings).30 We used an arbitrary assembly size
of.6.5 Mb as a threshold to identify any mixed sequences (including mix-
tures of the same species not identified by Kraken) and remove them from
the analysis. In silicomulti-locus sequence-typing (MLST) for K. pneumoniae
and E. cloacae isolates was performed using BLASTn of the sequence
assemblies against the MLST allele databases of these two species down-
loaded from https://pubmlst.org/general.shtml. Plasmid replicon typing
was performed using BLASTn against the PlasmidFinder database,31 and
IS typing using the ISFinder database.32 Resistance gene characterization
was performed using the in-house script ResistType, a BLASTn/local
reassembly-based approach for querying the presence/absence of known
chromosomal and acquired resistance mechanisms using a database as
described in Stoesser et al.33 (scripts and database available at: https://
github.com/hangphan/resistType_docker). This database includes .2000
variants from .70 resistance gene families, covering all the major resist-
ance gene mechanisms and many minor ones.
NDM-1 plasmid typing was performed using a reference database of
NDM-1 plasmids generated in this study and the subset harbouring NDM-1
from a curated database of plasmids downloaded from NCBI.34 BLASTn
was then used to query the sequence assemblies for the presence of similar
blaNDM-carrying plasmid structures. An isolate was characterized as having
candidate NDM-1-plasmid ‘X’ if.90% of plasmid ‘X’ could be aligned with
the query assembly’s contigs, where for each contig,.90% of the contig
length matched plasmid ‘X’ with.95% sequence identity. Thresholds were
set so that an isolate could have multiple matches to the NDM-1 plasmid
database.
Poretools35 was used to extract 2D reads from base-called MinION
sequencing data and Canu (v1.4)36 to generate de novo assemblies, which
were error-corrected using short-read Illumina data and the pilon assembly
polisher (v1.18).37 A plasmid was defined as circularized/complete if it
had.1 kb overlapping ends with.99% sequence identity. Alignments of
fully reconstructed plasmid sequences were visualized and annotated in
Geneious (version: R9).38
Data accession
All short-read sequencing data (fastq files) and long-read sequencing data
(assemblies) from the study are available in GenBank (BioProject accession:
PRJNA396838).
Results
Bacterial isolates
Four hundred and seventeen faecal/pharyngeal (n"135), staff
hand swabs (n"90) and environmental samples (n"192) were
collected from the neonatology unit during the Targu Mures sur-
veillance study, which overlapped with the major S. marcescens
outbreak period (January–May 2015). From these, 24
carbapenem-non-susceptible Enterobacteriaceae were cultured
(S. marcescens, n"19, K. pneumoniae, n"5; 19/19 S. marcescens
were found by PCR to carry blaNDM-1; 5/5 K. pneumoniaewere Carba
NP test-positive but not tested by PCR). Positive cultures were
obtained from faecal screens (n"14) and pharyngeal secretions
(n"7) from 14 neonates/children, and three environmental sam-
ples (one from a bed sheet, two from feeding tubes). NDM-1
S. marcescens neonatal bacteraemia isolates from the 2014–15
outbreak (n"5), carbapenem-susceptible S. marcescens from an
earlier outbreak (2010, n"3) and sporadic carbapenem-
susceptible S. marcescens cases (2012, n"3), as well as previous
sporadic NDM-1 K. pneumoniae (n"3, 2013) and NDM-1 E. cloacae
(n"3, 2013) were included. From Cluj-Napoca, five carbapenem
non-susceptible S. marcescens were obtained for comparison.
One sample was lost in processing, resulting in 45 sent for WGS
(Table S1, available as Supplementary data at JACOnline).
WGS data analysis
Forty-four of the 45 sequences passed assembly quality control,
including K. pneumoniae (n"7; 2 new ST, 3 ST-15, 1 ST-45, 1 ST-
307), E. cloacae (n"4; 2 ST-90, 1 ST-254, 1 ST-104) and
S. marcescens isolates (n"33; 27 NDM-1-positive; Figure S1).
The earliest confirmed NDM-1-positive strains of each species
were S. marcescens 7209 (28/03/2013) in Cluj-Napoca and in
Targu Mures E. cloacae 20ES (27/07/2013), K. pneumoniae
19ES (07/08/2013), and S. marcescens 12TM (22/10/2014).
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Phylogenetic analysis of S. marcescens isolates was consistent
with a clonal outbreak of NDM-1 S.marcescensacross clinical, envi-
ronmental and faecal screening isolates in the Targu Mures neona-
tal/paediatric units [,25 single nucleotide variations (SNVs)
distance across all isolates, 2014–15]. This clonal strain was
however chromosomally distantly related (.3300 SNVs) to the
2010–12 NDM-1-negative S. marcescens isolates from Targu
Mures and the 2013–15 NDM-1-positive S. marcescens isolates
from Cluj-Napoca (Figure 1). Other antimicrobial resistance genes
were common (Figure 1); two isolates, K. pneumoniae 17ES from
Targu Mures and S.marcescens9275 from Cluj-Napoca, harboured
both blaNDM-1 and blaOXA-48.
Long-read sequencing generated 12–98% coverage for the 10
isolates sequenced (Figure S2), confirmed the absence of blaNDM in
one S. marcescens isolate (14ES, 2012), and enabled closure of the
NDM-1 plasmid sequences (87.5–120 kb) in the other nine isolates
[S. marcescens (n"4), K. pneumoniae (n"3) and E. cloacae
(n"2); Table S2]. All nine NDM-1 plasmids shared high sequence
similarity with pKOX_NDM1 (accession number NC_021501.1), an
IncFIIY plasmid first identified in Taiwan in 2010
39 (Figure 2).
Several genetic changes with respect to pKOX_NDM1 were
observed in the study plasmids, including: scattered nucleotide
mutations; clusters of nucleotide mutations consistent with small
recombination events; and small and large indels. Examples of
indels included: (i) deletions of all or part of a cluster of genes
including cph (encoding for a bacterial phytochrome), merR (regu-
lator of the mer operon encoding for mercury resistance) and the
capsular polysaccharide biosynthesis operon (including kpsC),
the latter two of which have been associated with antimicrobial
resistance, environmental persistence and/or virulence40,41
(pNDM_22ES, pNDM_7209, pNDM_9580); (ii) deletions of several
open reading frames involved in conjugal transfer (pNDM_7209);
and (iii) acquisition of a set of putative phage-associated elements
in neonatal outbreak isolates from 2014 to 2015 (pNDM_12TM,
pNDM_4TM, pNDM_5TM, pNDM_6TM) (Figure 2). A large recombi-
nation event was also observed in pNDM_5TM and pNDM_6TM,
encompassing the region downstream of the putative phage to
traM (Figure 2), and genetically highly similar (99%) to 18 kb of
another reference plasmid, pCAV1344-78 (GenBank accession:
CP011621, Charlottesville, USA). This region contained two klcA
paralogues; klcA encodes for an anti-restriction protein, which has
recently been shown to promote horizontal gene transfer amongst
KPC plasmids.42
Plasmid typing of the other isolates (S. marcescens,
K. pneumoniae and E. cloacae) using short-read Illumina data
was consistent with pKOX_NDM1-like plasmids being present in
all NDM-1-positive strains, although the context and structure of
these plasmids could not be resolved from the Illumina
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assemblies. There were no significant matches to any non-
pKOX_NDM1 NDM-1-harbouring plasmids (Figure S1; all NDM-1-
harbouring isolates have a top match to pKOX_NDM1).
Discussion
Here, we show that the molecular epidemiology of carbapene-
mase-non-susceptible S. marcescens in two regional Romanian
hospitals is consistent with the emergence of multiple NDM-1
S. marcescens strain clusters in conjunction with pKOX_NDM1-like
plasmids, causing clinical outbreaks over 2013–15. NDM-1
S. marcescens was isolated from both asymptomatic neonates
and a small number of environmental samples, and caused
high rates of invasive disease (35%) in this susceptible
population. Highly genetically similar pKOX_NDM1-like plasmids
were observed in contemporaneously circulating E. cloacae and
K. pneumoniae, suggestive of a multi-species, multi-hospital
pKOX_NDM1-like plasmid transmission network, and acquisition of
this plasmid by genetically distinct strains of S. marcescens in
Targu Mures and Cluj-Napoca hospitals, causing the observed
outbreak in Targu Mures. Staff and environmental sampling failed
to identify a major non-patient reservoir, as elsewhere.10 Although
most NDM-1 S. marcescens isolates were obtained in the context
of the neonatal outbreak, several NDM-1 S. marcescens isolates
were from clinical specimens obtained from adults, suggesting
that these isolates are also important to consider in non-neonatal
patient groups.
There are limited data on carbapenemase-producing Entero-
bacteriaceae in Romania, but the earliest published reports of
NDM-1-producing Enterobacteriaceae in this country are from
Targu Mures hospital, one of our study hospitals. Surveillance
between January 2010 and September 2012 identified 9/2317
(0.3%) of non-duplicate Enterobacteriaceae as carbapenemase
producers, of which five harboured blaNDM-1 [E. cloacae n"2,
K. pneumoniae n"2 (one with OXA-181), E. coli n"1] and four
blaOXA-48 (K. pneumoniae n"3 and S.marcescens n"1).
43 Surveil-
lance of 100 isolates from 2011 mediated as part of the global
SENTRY antimicrobial resistance surveillance programme identi-
fied three CPE (3%), two of which were NDM-1 producers (both
E. cloacae; one from Bucharest and one from Cluj-Napoca), and
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one an OXA-48 producer (K. pneumoniae; from Bucharest).44 A
third study focusing on surveillance in Cluj-Napoca, August 2011–
November 2013,45 similarly identified 3% CPE prevalence (64/
1903 isolates tested; all in individuals.16 years of age), with the
earliest NDM-1 isolate an E. cloacae (26/9/2011) obtained from a
patient in ambulatory care, and the first NDM-1 S. marcescens iso-
late reportedly from February 2013. Although the sampling in
each of these studies was geographically and temporally
restricted, the data from these studies and our survey would sug-
gest that blaNDM-1 was present in non-Serratia spp. first, and subse-
quently emerged in Serratia spp.
Much of the recent surveillance of carbapenemase producers
unsurprisingly focuses on those species of Enterobacteriaceae that
cause most clinical disease, namely E. coli and/or K. pneumoniae.
The most recent report of the European Antimicrobial Resistance
Surveillance Network (EARS-Net) shows a significant increasing
trend in carbapenem resistance in both E. coli and K. pneumoniae
invasive isolates from Romania which is concerning.46 In addition,
a recent European-wide survey (EuSCAPE) investigating clinical iso-
lates of these two species suggested that in Romania most carba-
penem resistance was attributable to clonal dissemination of a
K. pneumoniae strain harbouring blaOXA-48.
47 Our data and other
recently published studies19,45,48,49 suggest that the epidemiology
of carbapenemase producers is more complicated, and different
mechanisms may be circulating in different species, with a degree
of horizontal exchange of successful plasmids. In Czobor et al.,48
several NDM-1 isolates were harbouring IncFIIY plasmids, consis-
tent with these being pKOX_NDM1-like, although with the limited
plasmid typing performed this cannot be confirmed. Surveillance is
therefore difficult, needs to encompass asymptomatic individuals
and a wide range of species types over time in order to be accurate,
and needs to be high resolution and comparable across studies.
A limitation of our study is that our strain collection was not
complete (i.e. did not include all NDM-positive isolates as well as
consecutive non-NDM isolates representing background diversity
for the two sites), but was predominantly focused on investigating
NDM-1 strains collected as part of outbreak investigation, and
sequencing of a small number of isolates that had been stored ad
hoc. Although WGS is now relatively commonly used for molecular
epidemiology and outbreak investigation, this is the first study to
our knowledge to use WGS data to investigate the evidence for
NDM-1 CPE transmission in Romania, and the mobile genetic ele-
ments involved in the acquisition and dissemination of blaNDM-1 in
nosocomial S. marcescens. The use of long-read WGS data to fully
resolve nine of the NDM-1 plasmid structures involved in this out-
break overcomes some of the pitfalls in investigating plasmid epi-
demiology using short-read WGS data, with which many plasmids
are only reconstructed as partial fragments or contigs. However,
evolutionary models to account for the genetic variation and plas-
ticity observed in these plasmid structures (mutations, recombina-
tion, indels) have not yet been developed, and it was not possible
to determine a clear sequence of plasmid transmission events by
visual inspection alone, particularly in view of the fact that we are
likely to have sampled only a proportion of potentially circulating
plasmids. We also cannot exclude the possibility of multiple, dis-
crete, pKOX_NDM1-like plasmid importation events into these
hospitals.
In this context, our phylogenetic analysis of bacterial strains
and high-resolution analysis of nine NDM-1 plasmids in circulating
K. pneumoniae, E. cloacae and S. marcescens would be consistent
with the transfer of pKOX_NDM1 from major non-Serratia spp. into
several S. marcescens host strains. We found no evidence of any
non-pKOX_NDM1-like plasmid backgrounds in the 34 NDM-1-
positive Enterobacteriaceae sequenced across the study time-
frame and two hospitals, which would be most consistent with the
importation of this plasmid type and its local dissemination,
as part of a pKOX_NDM1-like plasmid-associated outbreak, as
opposed to the emergence of a separate successful Romanian
NDM-1 plasmid. Further studies exploring the global diversity of
pKOX_NDM1-like plasmids, which have been reported in several
Enterobacteriaceae isolates from Canada,50 China,51 Australia/
New Zealand52 and Saudi Arabia53 would be useful to identify the
extent of transmission of this global, multi-species NDM-1 vector.
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